^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Kidney Cancer |
| Drug: | Opdivo (nivolumab) (PD1 inhibitor) + Cabometyx (cabozantinib tablet) (Multi-tyrosine kinase inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Kidney Cancer: Principles for systemic therapy for relapse or stage IV disease...Preferred Regimens...Cabozantinib + nivolumab (category 1)
